Bentiromide

Bentiromide is the dipeptide obtained by condensation of N-benzoyl-L-tyrosine with 4-aminobenzoic acid. Used as a noninvasive screening test for exocrine pancreatic insufficiency and to monitor the adequacy of supplemental pancreatic therapy, it is given by mouth: the amount of 4-aminobenzoic acid and its metabolites excreted in the urine is taken as a measure of the chymotrypsin-secreting activity of the pancreas. Among its listed roles, it functions as a diagnostic agent, an indicator and a reagent. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include Btpaba, Chymex and Bentiromidum. Its PubChem CID is 6957673.